13322  CGP 57380

MNK1 Inhibitor (CAS 522629-08-9)



• See below for pricing and ordering
• See more Inhibitors; Intracellular Signaling; Cell Biology; Inflammation; Signal Transduction

For active pharmaceutical ingredients (APIs) related to CGP 57380, see Cayman Pharma

CGP 57380 is a selective inhibitor of MAP kinase-interacting kinase 1 (MNK1) in vitro (IC50 = 2.2 μM),1 with no inhibitory activity against p38, JNK1, ERK1/2, PKC, or Src-like kinases. It blocks the phosphorylation of eIF4E in response to TNF-α, arsenite, anisomycin, PMA, or fetal calf serum in 293 cells (IC50 = 3 μM).1 CGP 57380 also dose-dependently inhibits TNF-α production in RAW 264.7 cells that have been co-treated with agonists for Toll-like receptor (TLR)2 (HKLM), TLR4 (LPS), TLR6/2 (FSL), TLR7 (imiquimod), or TLR9 (CpG DNA), presumably by inhibiting MNK1.2
1  missing reference text
2  missing reference text

Download Product Insert 108 Kb PDF
Download Material Safety Data Sheet (MSDS) 16 Kb PDF

Pricing Information

Prices listed here are the Manufacturer's Suggested European Retail Price. The actual prices quoted by each individual distributor may vary. Please visit the Global Buyer's Guide on the Cayman Chemical (world) website to locate a distributor in your region.

This product is also available to buy in bulk quantities. Please contact us for a quote or to purchase.

Cayman strives to be a reliable biochemical reagent vendor by providing the best possible products and services. To ask for assistance with one of our products please contact our Technical Help staff.

Warning This product is not for human or veterinary use.

Item total €0.00
Shopping cart total €0.00
Size Price Quantity
1 mg €38.00
5 mg €168.00
10 mg €298.00
25 mg €652.00
Pricing updated 2013-06-18.
Prices are subject to change without notice.